Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus
NCT05290506
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
PreDiabetes
Type 2 Diabetes
Interventions
DRUG:
Dipeptidyl-Peptidase IV Inhibitors
Sponsor
National University of Malaysia